Biotech: Pressemitteilungen - Kategorie - Seite 60

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Updated Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 European Cancer Congress

SAN FRANCISCO, CA: Updated Exploratory Analysis of Survival Indicates TNBC Patients in the Study Who Tested Positive for a Novel Gene Expression Profiling Assay Have to Date Experienced a 10.5-Month Longer Median Surviv ...

Atossa Genetics' Laboratory Receives ISO 15189:2012 Certification

SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 09/25/15 -- Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast hea ...

BIOflex Technologies Announces Listing on the Frankfurt Stock Exchange

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/22/15 -- BIOflex Technologies Inc. (TSX VENTURE: BFT)(FRANKFURT: 6BX) (the "Company" or "BIOflex") announces the listing of its common sha ...

Corbus Pharmaceuticals to Present Additional Data on the Effects of Resunab(TM) in the Treatment of Pulmonary Infection and Inflammation in Pre-Clinical Models of Cystic Fibrosis

NORWOOD, MA: Data to Be Presented at the North American Cystic Fibrosis Conference October 8-10, 2015; Resunab Demonstrated Improvement in Lung Inflammation and Infection in Cystic Fibrosis Pre-Clinical Model ...

SciVac Therapeutics Resumes Sci-B-Vac(TM) Standard Manufacturing

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/21/15 -- SciVac Therapeutics Inc. (TSX: VAC)(OTCQX: SVACF) announced today that its wholly-owned subsidiary SciVac Ltd. (the "Company") h ...

Sernova Announces Listing on OTCQB Exchange

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 09/21/15 -- Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a leading clinical stage, regenerative medicine company developing biologically compat ...

M Pharmaceutical Addresses Merger Rumours

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/21/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...

Theratechnologies to Announce Financial Results for the Third Quarter of 2015

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/21/15 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, ...

iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/21/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, today announced further di ...

Data From New Studies Confirm In Vitro Potency of VIBATIV(R) (Telavancin) Against Gram-Positive Bacteria, Including MRSA

DUBLIN, IRELAND: In Vitro Potency Results Presented at 2015 ICAAC Demonstrate Advantage for VIBATIV Against Difficult-to-Treat Infections as Compared to Vancomycin, Daptomycin and Linezolid ...

Atossa Genetics Announces FDA Acceptance of Its Investigational New Drug Application to Begin a Phase II Clinical Trial of Fulvestrant for the Treatment of DCIS

SEATTLE, WA: Study to Evaluate Fulvestrant Administered With Atossa's Patented Intraductal Microcatheters; Atossa Now Has Two Phase II Clinical Programs ...

Corbus Pharmaceuticals Commences Patient Enrollment in Phase 2 Clinical Study of Resunab(TM) for the Treatment of Cystic Fibrosis

NORWOOD, MA: Study in Cystic Fibrosis Is the Third Phase 2 Clinical Trial Underway With Resunab for Treatment of Rare, Serious Inflammatory and Fibrotic Diseases ...

Choate, Hall & Stewart Named 2015 "Patent Strategy and Management Team of the Year" by LMG Life Sciences

BOSTON, MA: BOSTON, MA -- (Marketwired) -- 09/17/15 -- announced today that the firm has been named the 2015 "Patent Strategy and Management Team of the Year" by LMG Life Sciences. The annual LMG Life ...

Arch Biopartners: AB569 Successfully Completes Pre-Clinical Validation Studies

TORONTO, CANADA: TORONTO, CANADA -- (Marketwired) -- 09/17/15 -- Arch Biopartners Inc (Arch) or (the Company) (TSX VENTURE: ACH)(OTCBB: FOIFF) announced AB569, the Company's drug candidate for treating pulmonar ...

M Pharmaceutical to Request DTC Eligibility to Improve Liquidity on the OTCQB

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/17/15 -- M Pharmaceutical Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2) (the "Company"), a clinical-stage company developing innovative t ...

Calyx's Subsidiary Cannigistics Announces Platform Licensing Agreement

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/17/15 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or "the Company") is pleased to announce that its wholly-owned sub ...

M Pharmaceutical to Present at Equities Pitch in Vancouver

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/16/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...

David Kaysen Named President & CEO of Sun BioPharma

MINNEAPOLIS, MN: Healthcare Executive Brings Extensive Clinical & Public Markets Experience to Sun's Management Team ...

Medivation Effects a Stock Dividend on Its Common Stock

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 09/16/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it has effected a stock dividend on its common stock, in which each outstanding share of common ...


Seite 60 von 255:  « ..  59 60 61  62  63  64  65  66  67  68  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z